TNFRSF8 and Hodgkins lymphoma: Both CD15 and CD30 were positive in 12 (80%) of 15 cases assessed, and they were both negative in the case of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and the case of unclassifiable HL.